Folgen
Myrto Samara
Myrto Samara
University of Thessaly
Bestätigte E-Mail-Adresse bei uth.gr - Startseite
Titel
Zitiert von
Zitiert von
Jahr
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
S Leucht, A Cipriani, L Spineli, D Mavridis, D Örey, F Richter, M Samara, ...
The Lancet 382 (9896), 951-962, 2013
30402013
Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis
M Huhn, A Nikolakopoulou, J Schneider-Thoma, M Krause, M Samara, ...
The Lancet 394 (10202), 939-951, 2019
13562019
Dose equivalents for antipsychotic drugs: the DDD method
S Leucht, M Samara, S Heres, JM Davis
Schizophrenia bulletin 42 (suppl_1), S90-S94, 2016
5942016
Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, Bayesian meta-analysis, and meta-regression of efficacy predictors
S Leucht, C Leucht, M Huhn, A Chaimani, D Mavridis, B Helfer, M Samara, ...
American Journal of Psychiatry 174 (10), 927-942, 2017
5562017
Efficacy of pharmacotherapy and psychotherapy for adult psychiatric disorders: a systematic overview of meta-analyses
M Huhn, M Tardy, LM Spineli, W Kissling, H Foerstl, G Pitschel-Walz, ...
JAMA psychiatry 71 (6), 706-715, 2014
4612014
Dose equivalents for second-generation antipsychotics: the minimum effective dose method
S Leucht, M Samara, S Heres, MX Patel, SW Woods, JM Davis
Schizophrenia bulletin 40 (2), 314-326, 2014
3842014
Efficacy, acceptability, and tolerability of antipsychotics in treatment-resistant schizophrenia: a network meta-analysis
MT Samara, M Dold, M Gianatsi, A Nikolakopoulou, B Helfer, G Salanti, ...
JAMA psychiatry 73 (3), 199-210, 2016
3532016
Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method
S Leucht, M Samara, S Heres, MX Patel, T Furukawa, A Cipriani, ...
Schizophrenia bulletin 41 (6), 1397-1402, 2015
2782015
Efficacy and safety of antidepressants added to antipsychotics for schizophrenia: a systematic review and meta-analysis
B Helfer, MT Samara, M Huhn, E Klupp, C Leucht, Y Zhu, RR Engel, ...
American Journal of Psychiatry 173 (9), 876-886, 2016
2562016
The longitudinal course of schizophrenia across the lifespan: clinical, cognitive, and neurobiological aspects
U Heilbronner, M Samara, S Leucht, P Falkai, TG Schulze
Harvard review of psychiatry 24 (2), 118-128, 2016
1792016
Antipsychotic drugs: from receptor-binding profiles to metabolic side effects
S Siafis, D Tzachanis, M Samara, G Papazisis
Current neuropharmacology 16 (8), 1210-1223, 2018
1702018
Early improvement as a predictor of later response to antipsychotics in schizophrenia: a diagnostic test review
MT Samara, C Leucht, MM Leeflang, IG Anghelescu, YC Chung, ...
American journal of psychiatry 172 (7), 617-629, 2015
1702015
Combining randomized and non‐randomized evidence in network meta‐analysis
O Efthimiou, D Mavridis, TPA Debray, M Samara, M Belger, GCM Siontis, ...
Statistics in medicine 36 (8), 1210-1226, 2017
1662017
Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies
TA Furukawa, SZ Levine, S Tanaka, Y Goldberg, M Samara, JM Davis, ...
JAMA psychiatry 72 (1), 14-21, 2015
1232015
How many patients with schizophrenia do not respond to antipsychotic drugs in the short term? An analysis based on individual patient data from randomized controlled trials
MT Samara, A Nikolakopoulou, G Salanti, S Leucht
Schizophrenia bulletin 45 (3), 639-646, 2019
1142019
Haloperidol versus first‐generation antipsychotics for the treatment of schizophrenia and other psychotic disorders
M Dold, MT Samara, C Li, M Tardy, S Leucht
Cochrane Database of Systematic Reviews, 2015
1112015
Equipercentile linking of scales measuring functioning and symptoms: examining the GAF, SOFAS, CGI-S, and PANSS
MT Samara, RR Engel, A Millier, J Kandenwein, M Toumi, S Leucht
European Neuropsychopharmacology 24 (11), 1767-1772, 2014
732014
Impact of Silymarin in individuals with nonalcoholic fatty liver disease: A systematic review and meta-analysis
G Kalopitas, C Antza, I Doundoulakis, A Siargkas, E Kouroumalis, ...
Nutrition 83, 111092, 2021
652021
Systematic review with meta‐analysis: the effect of vitamin E supplementation in adult patients with non‐alcoholic fatty liver disease
A Vadarlis, C Antza, DR Bakaloudi, I Doundoulakis, G Kalopitas, ...
Journal of Gastroenterology and Hepatology 36 (2), 311-319, 2021
612021
Recent meta-analyses neglect previous systematic reviews and meta-analyses about the same topic: a systematic examination
B Helfer, A Prosser, MT Samara, JR Geddes, A Cipriani, JM Davis, ...
BMC medicine 13, 1-8, 2015
602015
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–20